551 Health claim verifications avg. score 5.1/10 219 rated (mostly) true 266 rated (mostly) false
“Fear of public speaking, known as glossophobia, affects millions of people worldwide and can significantly limit personal growth.”
The core claim holds up well under scrutiny. Medical literature confirms that fear of public speaking affects roughly 15–30% of the global population, easily translating to hundreds of millions of people. The phrase "can significantly limit personal growth" is supported by documented evidence of avoidance behavior, missed career opportunities, and reduced participation — though this applies to a meaningful subset rather than all sufferers. The claim's careful use of "can" prevents it from being an overstatement, but it omits the fact that most people with this fear do not report significant daily impairment.
“Women who sleep naked next to their partners lose weight faster than women who sleep clothed in bed.”
No scientific study has ever tested whether women sleeping naked next to partners lose weight faster than those sleeping clothed. The claim stitches together unrelated findings — a five-man brown fat study, neonate skin-to-skin research, and general sleep-quality data — into a speculative chain that no evidence supports as a whole. Every credible medical source consulted explicitly states sleeping naked does not directly cause weight loss. The added detail about a partner's presence has zero basis in any published research.
“The FDA approved soy protein isolate at a daily intake of 25g despite its own safety committee recommending a maximum of 150mg per day.”
The central allegation — that an FDA safety committee recommended a 150mg/day maximum for soy protein isolate — is not supported by any FDA document, Federal Register entry, or peer-reviewed source in the evidentiary record. While the FDA did authorize a heart-health label claim tied to 25g/day of soy protein, and two individual FDA scientists raised concerns about isoflavone-related effects, no formal committee ever set a 150mg/day protein limit. The claim conflates milligram-range isoflavone discussions with gram-range protein intake and mischaracterizes individual dissent as an official committee recommendation.
“Doctronic, an AI company, is prescribing renewal medications to patients in Utah without physician involvement.”
Utah's Doctronic pilot is designed to eventually allow AI-driven prescription renewals without routine physician sign-off, but the claim significantly overstates current reality. As of early 2026, the program's active phase requires physician review of all renewals before they reach pharmacies. Even in later phases, escalation pathways to licensed physicians remain structurally embedded. The present-tense assertion of "no physician involvement" conflates the program's future autonomous design with its current operational requirements.
“Effective time management and maintaining positive social support networks are key strategies for university students to establish healthy boundaries between study, work, and rest.”
Strong peer-reviewed evidence supports both time management and social support as beneficial strategies for university students' wellbeing and stress reduction. Multiple systematic reviews and meta-analyses confirm these associations. However, the claim slightly overstates the evidence by framing these as strategies for "establishing healthy boundaries" specifically — the strongest empirical sources demonstrate wellbeing and stress outcomes rather than boundary-setting per se. The core practical message remains sound, but effect sizes for social support vary, and these strategies are not universally effective under heavy academic demands.
“Loss of smell (anosmia or olfactory dysfunction) is an early warning sign of Alzheimer's disease.”
Research consistently links olfactory decline to Alzheimer's-related biomarkers and future dementia risk, but the claim's framing overstates the connection. Smell loss is extremely common in normal aging, Parkinson's disease, Lewy body dementia, and many non-neurological conditions, making it far too nonspecific to serve as an Alzheimer's-specific warning sign. Major clinical authorities including the WHO and Mayo Clinic do not list it among primary early Alzheimer's symptoms. The evidence supports smell loss as a population-level risk indicator, not a reliable individual warning sign for Alzheimer's in particular.
“Loneliness is as harmful to human health as smoking 15 cigarettes per day.”
The comparison traces to a credible 2010 meta-analysis and was endorsed by the U.S. Surgeon General's 2023 Advisory, which states lacking social connection can increase premature death risk "as much as smoking up to 15 cigarettes a day." However, the claim drops the "up to" qualifier, conflates loneliness with broader social isolation, and presents a mortality-risk benchmark as a general health equivalence. At least one peer-reviewed cohort study found social isolation is actually less strongly linked to mortality than smoking, and a public health commentary warns the analogy oversimplifies the evidence.
“Fasting is not healthy for women who have high cortisol levels.”
While fasting does acutely raise cortisol and women show sex-specific changes in cortisol rhythm, the peer-reviewed evidence does not establish that fasting is clinically harmful for women with pre-existing high cortisol levels. The claim conflates a measurable hormonal response with demonstrated health harm—a logical leap unsupported by the highest-quality studies available. Sources making the stronger causal claim are predominantly wellness blogs and commercial health platforms, not clinical research on this specific population.
“Natural herbal remedies are inherently safer than pharmaceutical drugs.”
The scientific and medical evidence overwhelmingly contradicts the assertion that herbal remedies are "inherently safer" than pharmaceutical drugs. Multiple high-authority sources — including the NCCIH, WHO, Mayo Clinic, and numerous peer-reviewed systematic reviews — document serious adverse events from herbal products, including hepatotoxicity, renal failure, and death. The apparent safety record of herbal remedies largely reflects regulatory and surveillance gaps, not actual safety. No credible scientific authority endorses the premise that natural origin confers an inherent safety advantage.
“Chamomile tea has clinically demonstrated effects in reducing anxiety symptoms.”
Clinical trial evidence does support chamomile's anxiety-reducing effects, though the claim overstates the strength and scope of that evidence. A peer-reviewed, placebo-controlled trial found statistically significant reductions in anxiety scores, and a systematic review of 10 trials found 9 reporting positive results. However, most studies used standardized chamomile extract — not brewed tea — and effects are characterized as modest, primarily in mild-to-moderate generalized anxiety disorder. The claim is directionally accurate but lacks important qualifiers.
“Ginger is effective at reducing nausea in humans.”
Ginger's anti-nausea effect in humans is supported by a substantial body of evidence, though its strength varies by context. Multiple meta-analyses report statistically significant nausea reduction in pregnancy and postoperative settings, and ACOG endorses ginger as a first-line nonpharmacologic option for pregnancy nausea. However, evidence for chemotherapy-induced nausea in adults is weak or negative, and authoritative reviews (NCCIH, Cochrane) flag generally low-to-moderate evidence quality. The claim is directionally accurate but overstates the uniformity and certainty of the evidence.
“Lemon balm (Melissa officinalis) reduces anxiety and produces a calming effect on the nervous system.”
Multiple randomized, double-blind, placebo-controlled trials and a meta-analysis confirm that lemon balm supplementation can reduce anxiety and produce calming effects, supported by a well-characterized GABAergic mechanism. However, the claim is somewhat overstated: most positive trials used proprietary standardized extracts (e.g., Cyracos) in populations pre-selected for emotional distress or comorbid conditions, and the meta-analysis flagged high heterogeneity. The effect is real but mild compared to pharmaceutical anxiolytics, and results may not generalize to all lemon balm products or all populations.
“Vaping causes cancer in humans.”
Current evidence does not support the definitive claim that vaping causes cancer in humans. Human studies showing elevated cancer risk involve dual users who also smoke combustible cigarettes — a known carcinogen — making it impossible to isolate vaping as the independent cause. Multiple systematic reviews find no significant cancer risk in exclusive never-smoker vapers. While biomarker evidence of DNA damage and a recent review calling vaping "likely" carcinogenic suggest biological plausibility, no authoritative body has confirmed a definitive causal link for vaping alone.
“Drinking 3 to 5 cups of coffee per day reduces the risk of cardiovascular disease.”
Large meta-analyses of prospective cohort studies consistently find that drinking 3–5 cups of coffee per day is associated with the lowest observed cardiovascular disease risk — but the claim's causal framing ("reduces the risk") overstates what observational evidence can establish. Residual confounding, variation in cup size and caffeine content, individual genetic differences, and inconsistent findings for specific endpoints like coronary heart disease all represent material omissions. The direction of the evidence is favorable, but the certainty implied by the claim is not warranted.
“The use of antibacterial soaps contributes to the development of antibiotic resistance.”
Strong mechanistic and regulatory evidence supports that antibacterial soaps — particularly those containing triclosan — contribute to antibiotic resistance development. Multiple peer-reviewed studies show triclosan exposure selects for bacteria with cross-resistance to clinical antibiotics, and the FDA banned triclosan from consumer soaps in 2016 partly on these grounds. However, the claim overgeneralizes: triclosan-based soaps are now largely off the market, the evidence gap between laboratory findings and real-world population-level causation persists, and not all antibacterial soap ingredients carry the same risk profile.
“Improving sleep quality significantly reduces anxiety and psychological stress levels.”
Strong evidence from multiple peer-reviewed studies and meta-analyses confirms that improving sleep quality significantly reduces anxiety symptoms. However, the claim overstates the case for psychological stress: a 2025 meta-analysis found no significant difference in stress levels compared to standard care when sleep was improved. The sleep-anxiety relationship is also bidirectional, meaning reduced anxiety can itself improve sleep. The claim is well-grounded for anxiety but less conclusively supported for stress reduction specifically.
“Ashwagandha supplementation effectively reduces stress and lowers cortisol levels in humans.”
Multiple systematic reviews and meta-analyses — including a 2025 BJPsych Open analysis of 15 studies — consistently show ashwagandha reduces perceived stress and cortisol levels compared to placebo. However, these benefits are best demonstrated in chronically stressed adults, not the general population. Evidence certainty is rated "low" with high heterogeneity across trials, at least one RCT found no cortisol effect in a specific subgroup, and long-term safety data remain limited. The claim is substantively supported but overstates universality.
“Adrenal fatigue syndrome is a recognized medical condition in which overworked adrenal glands produce insufficient cortisol.”
Every major medical authority — including the Endocrine Society, NIDDK, Mayo Clinic, and Cleveland Clinic — explicitly states that "adrenal fatigue" is not a recognized medical diagnosis and lacks scientific proof. A 2016 systematic review in a peer-reviewed journal found no substantiation for the concept. While adrenal insufficiency (e.g., Addison's disease) is a real condition involving low cortisol, it has distinct causes unrelated to the "overworked adrenals" mechanism described in the claim. The only sources supporting the claim come from low-authority integrative or commercial health websites.
“Pregnant women should avoid eating crab due to health risks.”
This claim is false. Major health authorities including the EPA, FDA, and NHS do not advise pregnant women to avoid crab. The EPA-FDA explicitly lists crab as a "Best Choice" seafood for pregnant women due to its low mercury content. The NHS caution applies only to raw or undercooked shellfish, not properly cooked crab. Guidance recommends eating cooked crab within standard seafood serving limits — not avoiding it entirely. A blanket avoidance recommendation is unsupported and could deprive mothers and babies of beneficial nutrients.
“Consuming caffeine while cortisol levels are elevated reduces the stimulant effect of caffeine compared to when cortisol levels are not elevated.”
The available evidence does not support this claim as stated. Studies show that habitual caffeine use can blunt caffeine's ability to further raise cortisol levels — but this is a different outcome from caffeine's stimulant effect on alertness, which is primarily mediated through adenosine receptor blockade. No source in the evidence pool directly measures whether pre-existing elevated cortisol reduces caffeine's wakefulness or alertness properties. The claim conflates two distinct physiological pathways, creating a materially misleading impression.